Two pathways.
One result.
Compounded tirzepatide with B12 — a dual GIP/GLP-1 receptor agonist — hits two appetite pathways instead of one, in a once-weekly clinician-titrated injection.
Compounded by a state-licensed 503A pharmacy from a patient-specific prescription. Not FDA-approved.Prescribed only when clinically appropriate, at a licensed provider's discretion. Available nationwide by telehealth — see our States page for current coverage. Not sure which GLP-1 fits? Compare weight-loss programs →
The dual-pathway option.
Tirzepatide works GLP-1 and GIP receptors together — two appetite pathways instead of one.
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Your clinician steps the dose up gradually and reviews how you respond at each check-in. Compounded tirzepatide is not FDA-approved.
Titration is gradual and clinician-managed, so results build without your week falling apart around side effects.
How tirzepatide actually works.
Plain answers to what your clinician will cover, no forum myths.
What is tirzepatide?+
A dual GIP/GLP-1 receptor agonist — it mimics two gut hormones that regulate appetite and blood sugar, not just one. LodeRx uses compounded tirzepatide with B12 from state-licensed US pharmacies under Section 503A of the FD&C Act, prescribed by a clinician when appropriate. Compounded medications are not FDA-approved.
How is it different from semaglutide?+
Semaglutide works one receptor (GLP-1); tirzepatide works two (GLP-1 + GIP). The added pathway influences appetite and how your body handles energy. Your clinician helps you pick based on your history and response.
Is it right for me?+
Typically for adults with a qualifying BMI or weight-related condition — your clinician decides from your history. A personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or pregnancy are among the reasons it may not be appropriate.
What about side effects?+
Same class profile: gastrointestinal effects — nausea, constipation, reflux — mostly during dose ramp, easing over time for most. Your clinician controls the titration and adjusts if it's rough; that's what the check-ins are for.
Three steps to the dual-pathway option.
Choose your plan and complete a short medical intake — history, weight goals, any conditions. Prefer to talk first? Request a call.
A provider licensed in your state reviews your file and decides if tirzepatide is the right tool — or whether semaglutide gets it done for less.
Medication arrives from a certified US pharmacy with syringes included. Your care team guides the weekly ramp and check-ins.
Asked constantly. Answered honestly.
Why is compounded tirzepatide priced differently from FDA-approved GLP-1 medications?+
They are different products. Compounded tirzepatide is prepared by a state-licensed 503A pharmacy for one patient from a clinician's prescription. It is not FDA-approved and is not a generic or a substitute for an FDA-approved drug. Your clinician decides whether it is appropriate for you; our price covers the consultation, medication, and shipping.
Should I start on tirzepatide or semaglutide?+
Honest answer: semaglutide costs less, and tirzepatide is a dual-pathway option your clinician may consider based on your history and response. That call happens in your review, not at checkout.
How fast will I see results?+
Everyone responds differently; your clinician reviews your progress at each check-in and adjusts the dose as it titrates. The dual pathway doesn't change the rule: steady beats dramatic.
Can I use HSA/FSA, and can I stop?+
Many members use HSA/FSA funds — check your plan. No contracts; cancel before your next renewal. If you stop, your clinician advises on maintenance and what to expect.
Deals, new science, and new programs.
Join the list for member pricing, the latest research on hormones and longevity, and first access to new programs.